Concepedia

Jagannath Pal

JP

11

Publications

470

Citations

11

H-Index

2009

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

VA Boston Healthcare System

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Jagannath Pal is an author at Dana-Farber Cancer Institute specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

2009–2023

11

Publications

11

Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells

Sanjeev Kumar, Christopher S. Bryant, Sreedhar Chamala et al. · Molecular Cancer · 2009 · 92 citations · Full text

Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy

Aamer Qazi, Jagannath Pal, Ma'in Y. Maitah et al. · Translational Oncology · 2010 · 85 citations · Full text

Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells

Christopher S. Bryant, Sanjeev Kumar, Sreedhar Chamala et al. · Molecular Cancer · 2010 · 72 citations · Full text

Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome

Jagannath Pal, Robert C. Bertheau, Leutz Buon et al. · Oncogene · 2011 · 63 citations

, , +9

Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance

Subodh Kumar, Srikanth Talluri, Jagannath Pal et al. · Blood Cancer Journal · 2018 · 50 citations · Full text

Rows per page

1–5 of 11